Skip to main content
Acta Crystallographica Section E: Structure Reports Online logoLink to Acta Crystallographica Section E: Structure Reports Online
. 2008 Oct 31;64(Pt 11):o2238. doi: 10.1107/S1600536808034867

(E)-3-(3-Bromo­phen­yl)-1-(4-methyl­phenyl)prop-2-en-1-one

Hongqi Li a,*, B K Sarojini b, C G D Raj b, L N Madhu b, H S Yathirajan c
PMCID: PMC2959749  PMID: 21581092

Abstract

The title compound, C16H13BrO, was synthesized from the reaction of 3-bromo­benzaldehyde and 4-methyl­acetophenone in the presence of KOH. The mol­ecule adopts an E configuration with respect to the C=C double bond of the propenone unit. The dihedral angle formed by the aromatic rings is 46.91 (14)°. The crystal structure is stabilized by Br⋯Br inter­actions [3.4549 (11) Å].

Related literature

For the properties and applications of chalcones, see: Pandey et al. (2005); Conti (2006); Lawrence et al. (2001); Nielsen et al. (2005); Dominguez et al. (2005). For related structures, see: Sarojini et al. (2007) and references cited therein.graphic file with name e-64-o2238-scheme1.jpg

Experimental

Crystal data

  • C16H13BrO

  • M r = 301.17

  • Triclinic, Inline graphic

  • a = 5.8984 (16) Å

  • b = 7.3015 (19) Å

  • c = 15.559 (4) Å

  • α = 83.461 (5)°

  • β = 87.860 (4)°

  • γ = 88.446 (5)°

  • V = 665.1 (3) Å3

  • Z = 2

  • Mo Kα radiation

  • μ = 3.08 mm−1

  • T = 273 (2) K

  • 0.12 × 0.10 × 0.06 mm

Data collection

  • Bruker SMART CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 2004) T min = 0.709, T max = 0.837

  • 3407 measured reflections

  • 2312 independent reflections

  • 1457 reflections with I > 2σ(I)

  • R int = 0.049

Refinement

  • R[F 2 > 2σ(F 2)] = 0.058

  • wR(F 2) = 0.168

  • S = 1.00

  • 2312 reflections

  • 163 parameters

  • H-atom parameters constrained

  • Δρmax = 0.57 e Å−3

  • Δρmin = −0.44 e Å−3

Data collection: SMART (Bruker, 2001); cell refinement: SAINT (Bruker, 2001); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL.

Supplementary Material

Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536808034867/rz2257sup1.cif

e-64-o2238-sup1.cif (16.8KB, cif)

Structure factors: contains datablocks I. DOI: 10.1107/S1600536808034867/rz2257Isup2.hkl

e-64-o2238-Isup2.hkl (113.6KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report

Acknowledgments

BKS thanks BRNS, DAE, Government of India (grant No. 2008/34/05-BRNS/457).

supplementary crystallographic information

Comment

Chalcones are a class of naturally occurring compounds with interesting biological properties such as cytotoxicity (Pandey et al., 2005), antiherpes activity and antitumour activity (Conti, 2006) and may be useful for the chemotherapy of leishmaniasis among others (Lawrence et al., 2001). Chalcone derivatives are also used as antibiotics (Nielsen et al., 2005) and as anti malerials (Dominguez et al., 2005). Recently, the crystal structures of some methyl- and bromo-substituted chalcones have been reported by our group (Sarojini et al., 2007 and references cited therein). In a continuation of our studies, the title chalcone derivative was synthesized and its crystal structure is reported here.

The molecule of the title compound (Fig. 1) adopts an E configuration with respect to the C═C double bond of the propenone unit. The two aromatic rings are not coplanar, they dihedral angle they form being 46.91 (14) °. Molecular dimensions are unexceptional. The crystal structure is stabilized by Br···Br interactions occurring between centrosymmetrically-related molecules [Br1···Br1i = 3.4549 (11) Å; symmetry code: (i) -x, 2-y, -z].

Experimental

The title compound was prepared by adding 50% KOH (2.5 ml) to a solution of 4-methylacetophenone (1.34 g, 0.01 mol) and 3-bromobenzaldehyde (1.86 g, 0.01 mol) in ethanol (25 ml) at 273 K. The mixture was stirred for an hour and poured into crushed ice. The resulting yellow precipitate was collected by filtration and purified by recrystallization from ethanol. Single crystals suitable for X-ray analysis were grown by slow evaporation of an acetone solution (yield 80%). Analytical data: found (calculated): C %, 63.78 (63.81); H%, 4.30 (4.35).

Refinement

All H atoms were placed at calculated positions and refined using the riding model approximation, with C—H = 0.93-0.96 Å and with Uiso(H) = 1.2 Ueq(C) or 1.5 Ueq(C) for methyl H atoms.

Figures

Fig. 1.

Fig. 1.

A view of the molecule of the title compound. Displacement ellipsoids are drawn at the 30% probability level and H atoms are shown as small spheres of arbitrary radii.

Crystal data

C16H13BrO Z = 2
Mr = 301.17 F(000) = 304
Triclinic, P1 Dx = 1.504 Mg m3
Hall symbol: -P 1 Melting point = 378–380 K
a = 5.8984 (16) Å Mo Kα radiation, λ = 0.71073 Å
b = 7.3015 (19) Å Cell parameters from 1237 reflections
c = 15.559 (4) Å θ = 2.6–23.7°
α = 83.461 (5)° µ = 3.08 mm1
β = 87.860 (4)° T = 273 K
γ = 88.446 (5)° Block, colourless
V = 665.1 (3) Å3 0.12 × 0.10 × 0.06 mm

Data collection

Bruker SMART CCD area-detector diffractometer 2312 independent reflections
Radiation source: fine-focus sealed tube 1457 reflections with I > 2σ(I)
graphite Rint = 0.049
φ and ω scans θmax = 25.1°, θmin = 2.8°
Absorption correction: multi-scan (SADABS; Sheldrick, 2004) h = −7→6
Tmin = 0.709, Tmax = 0.837 k = −8→6
3407 measured reflections l = −18→18

Refinement

Refinement on F2 Primary atom site location: structure-invariant direct methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.058 Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.168 H-atom parameters constrained
S = 1.00 w = 1/[σ2(Fo2) + (0.078P)2 + 0.164P] where P = (Fo2 + 2Fc2)/3
2312 reflections (Δ/σ)max < 0.001
163 parameters Δρmax = 0.57 e Å3
0 restraints Δρmin = −0.44 e Å3

Special details

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
Br1 0.20271 (11) 0.91736 (11) 0.07283 (4) 0.0905 (4)
O1 −0.2214 (6) 0.7140 (5) 0.5453 (2) 0.0640 (10)
C1 0.3158 (8) 0.9176 (7) 0.1855 (3) 0.0522 (13)
C2 0.1824 (8) 0.8504 (7) 0.2552 (3) 0.0475 (12)
H2 0.0413 0.8024 0.2469 0.057*
C3 0.2584 (7) 0.8541 (6) 0.3379 (3) 0.0436 (11)
C4 0.4711 (8) 0.9273 (6) 0.3481 (3) 0.0474 (12)
H4 0.5246 0.9308 0.4033 0.057*
C5 0.6015 (8) 0.9939 (7) 0.2770 (4) 0.0512 (13)
H5 0.7434 1.0412 0.2844 0.061*
C6 0.5234 (8) 0.9912 (7) 0.1949 (4) 0.0556 (13)
H6 0.6100 1.0385 0.1466 0.067*
C7 0.1059 (7) 0.7893 (6) 0.4108 (3) 0.0458 (12)
H7 −0.0429 0.7673 0.3978 0.055*
C8 0.1579 (8) 0.7590 (7) 0.4923 (3) 0.0519 (13)
H8 0.3069 0.7715 0.5079 0.062*
C9 −0.0197 (8) 0.7046 (6) 0.5605 (3) 0.0476 (12)
C10 0.0571 (7) 0.6411 (6) 0.6491 (3) 0.0433 (11)
C11 0.2715 (8) 0.5634 (7) 0.6637 (4) 0.0502 (12)
H11 0.3718 0.5491 0.6172 0.060*
C12 0.3359 (8) 0.5073 (7) 0.7474 (4) 0.0518 (13)
H12 0.4773 0.4506 0.7567 0.062*
C13 0.1921 (8) 0.5347 (7) 0.8172 (3) 0.0503 (12)
C14 −0.0198 (8) 0.6113 (7) 0.8023 (3) 0.0544 (13)
H14 −0.1188 0.6276 0.8489 0.065*
C15 −0.0881 (8) 0.6646 (6) 0.7191 (3) 0.0468 (12)
H15 −0.2322 0.7164 0.7101 0.056*
C16 0.2693 (12) 0.4783 (10) 0.9080 (4) 0.0823 (19)
H16A 0.1875 0.5502 0.9474 0.123*
H16B 0.4289 0.4988 0.9104 0.123*
H16C 0.2405 0.3499 0.9240 0.123*

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
Br1 0.0839 (5) 0.1354 (8) 0.0529 (5) −0.0024 (4) −0.0134 (3) −0.0102 (4)
O1 0.043 (2) 0.084 (3) 0.064 (2) −0.0043 (17) −0.0094 (17) −0.002 (2)
C1 0.050 (3) 0.063 (3) 0.044 (3) 0.006 (2) −0.003 (2) −0.005 (2)
C2 0.038 (2) 0.053 (3) 0.052 (3) 0.001 (2) −0.007 (2) −0.009 (2)
C3 0.037 (2) 0.042 (3) 0.052 (3) 0.002 (2) 0.000 (2) −0.009 (2)
C4 0.039 (3) 0.050 (3) 0.055 (3) −0.001 (2) −0.005 (2) −0.015 (2)
C5 0.039 (3) 0.048 (3) 0.068 (4) −0.002 (2) −0.004 (3) −0.012 (3)
C6 0.048 (3) 0.060 (3) 0.057 (3) 0.001 (2) 0.007 (2) −0.004 (3)
C7 0.036 (2) 0.045 (3) 0.059 (3) −0.002 (2) −0.009 (2) −0.012 (2)
C8 0.043 (3) 0.058 (3) 0.056 (3) −0.007 (2) −0.007 (2) −0.010 (3)
C9 0.042 (3) 0.039 (3) 0.063 (3) −0.007 (2) 0.001 (2) −0.009 (2)
C10 0.037 (2) 0.036 (3) 0.057 (3) −0.0047 (19) −0.003 (2) −0.005 (2)
C11 0.039 (3) 0.049 (3) 0.062 (3) −0.003 (2) 0.011 (2) −0.010 (3)
C12 0.039 (3) 0.046 (3) 0.068 (4) 0.000 (2) −0.004 (3) 0.003 (3)
C13 0.049 (3) 0.047 (3) 0.053 (3) −0.007 (2) 0.000 (2) −0.001 (2)
C14 0.047 (3) 0.062 (3) 0.054 (3) −0.003 (2) 0.011 (2) −0.008 (3)
C15 0.038 (2) 0.043 (3) 0.058 (3) −0.002 (2) 0.005 (2) −0.005 (2)
C16 0.085 (4) 0.091 (5) 0.069 (4) 0.000 (4) −0.011 (4) 0.002 (4)

Geometric parameters (Å, °)

Br1—C1 1.899 (5) C8—H8 0.9300
O1—C9 1.220 (6) C9—C10 1.486 (7)
C1—C2 1.368 (7) C10—C15 1.383 (7)
C1—C6 1.370 (7) C10—C11 1.388 (6)
C2—C3 1.382 (6) C11—C12 1.384 (7)
C2—H2 0.9300 C11—H11 0.9300
C3—C4 1.398 (6) C12—C13 1.382 (7)
C3—C7 1.464 (7) C12—H12 0.9300
C4—C5 1.374 (7) C13—C14 1.373 (7)
C4—H4 0.9300 C13—C16 1.510 (8)
C5—C6 1.377 (7) C14—C15 1.380 (7)
C5—H5 0.9300 C14—H14 0.9300
C6—H6 0.9300 C15—H15 0.9300
C7—C8 1.309 (7) C16—H16A 0.9600
C7—H7 0.9300 C16—H16B 0.9600
C8—C9 1.491 (7) C16—H16C 0.9600
C2—C1—C6 122.1 (5) C10—C9—C8 117.6 (4)
C2—C1—Br1 118.6 (4) C15—C10—C11 119.2 (5)
C6—C1—Br1 119.3 (4) C15—C10—C9 118.8 (4)
C1—C2—C3 119.6 (4) C11—C10—C9 122.0 (4)
C1—C2—H2 120.2 C12—C11—C10 119.9 (5)
C3—C2—H2 120.2 C12—C11—H11 120.0
C2—C3—C4 118.7 (5) C10—C11—H11 120.0
C2—C3—C7 117.9 (4) C13—C12—C11 120.7 (4)
C4—C3—C7 123.3 (4) C13—C12—H12 119.7
C5—C4—C3 120.4 (5) C11—C12—H12 119.7
C5—C4—H4 119.8 C14—C13—C12 119.1 (5)
C3—C4—H4 119.8 C14—C13—C16 121.2 (5)
C4—C5—C6 120.4 (4) C12—C13—C16 119.7 (5)
C4—C5—H5 119.8 C13—C14—C15 120.9 (5)
C6—C5—H5 119.8 C13—C14—H14 119.6
C1—C6—C5 118.7 (5) C15—C14—H14 119.6
C1—C6—H6 120.6 C14—C15—C10 120.2 (4)
C5—C6—H6 120.6 C14—C15—H15 119.9
C8—C7—C3 126.6 (4) C10—C15—H15 119.9
C8—C7—H7 116.7 C13—C16—H16A 109.5
C3—C7—H7 116.7 C13—C16—H16B 109.5
C7—C8—C9 120.6 (5) H16A—C16—H16B 109.5
C7—C8—H8 119.7 C13—C16—H16C 109.5
C9—C8—H8 119.7 H16A—C16—H16C 109.5
O1—C9—C10 120.6 (5) H16B—C16—H16C 109.5
O1—C9—C8 121.8 (5)
C6—C1—C2—C3 −0.7 (7) O1—C9—C10—C15 −26.2 (7)
Br1—C1—C2—C3 −178.1 (3) C8—C9—C10—C15 152.7 (4)
C1—C2—C3—C4 0.1 (7) O1—C9—C10—C11 155.4 (5)
C1—C2—C3—C7 177.1 (4) C8—C9—C10—C11 −25.7 (6)
C2—C3—C4—C5 0.0 (7) C15—C10—C11—C12 1.3 (7)
C7—C3—C4—C5 −176.8 (4) C9—C10—C11—C12 179.6 (4)
C3—C4—C5—C6 0.6 (7) C10—C11—C12—C13 −2.7 (7)
C2—C1—C6—C5 1.3 (8) C11—C12—C13—C14 2.8 (7)
Br1—C1—C6—C5 178.7 (4) C11—C12—C13—C16 −177.9 (5)
C4—C5—C6—C1 −1.3 (7) C12—C13—C14—C15 −1.5 (7)
C2—C3—C7—C8 170.1 (5) C16—C13—C14—C15 179.2 (5)
C4—C3—C7—C8 −13.1 (7) C13—C14—C15—C10 0.1 (7)
C3—C7—C8—C9 176.0 (4) C11—C10—C15—C14 0.0 (7)
C7—C8—C9—O1 −11.5 (7) C9—C10—C15—C14 −178.4 (4)
C7—C8—C9—C10 169.6 (4)

Footnotes

Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: RZ2257).

References

  1. Bruker (2001). SMART and SAINT Bruker AXS Inc., Madison, Wisconsin, USA.
  2. Conti, M. (2006). Anticancer Drugs, 17, 1017–1022. [DOI] [PubMed]
  3. Dominguez, J. N., Leon, C., Rodrigues, J., De Dominguez, N. G., Gut, J. & Rosenthal, P. J. (2005). Farmaco, 60, 307–311. [DOI] [PubMed]
  4. Lawrence, N. J., Rennison, D., McGown, A. T., Ducki, S., Gul, L. A., Hadfield, J. A. & Khan, N. (2001). J. Comb. Chem.3, 421–426. [DOI] [PubMed]
  5. Nielsen, S. F., Larsen, M., Boesen, T., Schonning, K. & Kromann, H. (2005). J. Med. Chem.48, 2667–2677. [DOI] [PubMed]
  6. Pandey, S., Suryawanshi, S. N., Gupta, S. & Srivastava, V. M. L. (2005). Eur. J. Med. Chem.40, 751–756. [DOI] [PubMed]
  7. Sarojini, B. K., Yathirajan, H. S., Mustafa, K., Sarfraz, H. & Bolte, M. (2007). Acta Cryst. E63, o4477.
  8. Sheldrick, G. M. (2004). SADABS University of Göttingen, Germany.
  9. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536808034867/rz2257sup1.cif

e-64-o2238-sup1.cif (16.8KB, cif)

Structure factors: contains datablocks I. DOI: 10.1107/S1600536808034867/rz2257Isup2.hkl

e-64-o2238-Isup2.hkl (113.6KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Structure Reports Online are provided here courtesy of International Union of Crystallography

RESOURCES